The rTg4510 model overexpresses doxycycline-repressible human mutant tau with the MAPT P301L mutation, which is associated with genetic forms of FTD-tau, under the control of the Ca2+-calmodulin-dependent protein kinase II (CaMKII) promoter [4]. This evidence concerns the gene MAPT and frontotemporal dementia.